MYC and cancer: The downregulation of SSeCKS expression is associated with cancer malignancy parameters such as metastasis and recurrence [23], and indeed, SSeCKS is downregulated by oncogenes known to be especially activated in cancer malignancy such as Src, Ras and Myc [24].